Moderna announced preliminary booster data and updated strategy to address Omicron variant

, , ,

On Dec. 20, 2021, Moderna announced preliminary neutralizing antibody data against the Omicron variant following the Company’s booster candidates at 50 ᄉg and 100 ᄉg dose levels.

The currently authorized 50 ᄉg booster of mRNA-1273 increased neutralizing antibody levels against Omicron approximately 37-fold compared to pre-boost levels and a 100 ᄉg dose of mRNA-1273 increased neutralizing antibody levels approximately 83-fold compared to pre-boost levels.

Tags:


Source: Moderna
Credit: Photo: Colorized scanning electron micrograph of a cell (red) infected with the Omicron strain of SARS-CoV-2 virus particles (blue), Fort Detrick, Maryland. Courtesy: National Institute of Allergy and Infectious Diseases.